ABOUT THE RESEARCHER

OVERVIEW

Mari M. Nakamura, MD, MPH, is a pediatric infectious diseases physician and health services and health policy researcher.  Her work focuses on pediatric healthcare quality, including measurement of hospital quality, the effects of health policy on pediatric care, and the use of health information technology to improve care. 

As a member of the Boston Children’s Hospital Center of Excellence for Pediatric Quality Measurement, Dr. Nakamura developed pediatric readmission quality measures for national use by the Agency for Healthcare Research and Quality and the Centers for Medicare & Medicaid Services.  She is also conducting studies on electronic health record adoption by U.S. children’s hospitals.

 

BACKGROUND

Dr. Nakamura received her MD from Washington University School of Medicine in 1999.  She completed pediatric residency training at Vanderbilt Children’s Hospital in 2002 and pediatric infectious diseases fellowship training at Lucile Packard Children’s Hospital at Stanford in 2006.  She came to Boston Children’s Hospital in 2006 to join the Harvard Pediatric Health Services Research Fellowship Program and became a faculty member in 2009.  She received an MPH from the Harvard School of Public Health in 2008. 

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc. 2021 Feb 13; 10(1):34-48. View abstract
  2. Variability in Ceftriaxone Dosing Across 32 US Acute Care Children's Hospitals. J Pediatric Infect Dis Soc. 2021 Feb 02. View abstract
  3. Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of COVID-19 in Children and Adolescents. J Pediatric Infect Dis Soc. 2021 Jan 03. View abstract
  4. Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc. 2020 Dec 31; 9(6):701-715. View abstract
  5. Encouraging Entrustment: A Qualitative Study of Resident Behaviors That Promote Entrustment. Acad Med. 2020 11; 95(11):1718-1725. View abstract
  6. A Call for Pediatric COVID-19 Clinical Trials. Pediatrics. 2020 08; 146(2). View abstract
  7. Potential Impact of Initial Clinical Data on Adjustment of Pediatric Readmission Rates. Acad Pediatr. 2019 07; 19(5):589-598. View abstract
  8. Safety and Tolerability of Moxifloxacin in Children. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):e92-e101. View abstract
  9. Safety of Outpatient Parenteral Antimicrobial Therapy in Children. Pediatr Infect Dis J. 2018 02; 37(2):157-163. View abstract
  10. Readmission After Pediatric Mental Health Admissions. Pediatrics. 2017 Dec; 140(6). View abstract
  11. Pediatric Readmissions After Hospitalizations for Lower Respiratory Infections. Pediatrics. 2017 Aug; 140(2). View abstract
  12. Same-Hospital Readmission Rates as a Measure of Pediatric Quality of Care. JAMA Pediatr. 2015 Oct; 169(10):905-12. View abstract
  13. Factors associated with meaningful use incentives in children's hospitals. Pediatrics. 2015 Jun; 135(6):e1409-16. View abstract
  14. Impact of the meaningful use incentive program on electronic health record adoption by US children's hospitals. J Am Med Inform Assoc. 2015 Mar; 22(2):390-8. View abstract
  15. Measuring pediatric hospital readmission rates to drive quality improvement. Acad Pediatr. 2014 Sep-Oct; 14(5 Suppl):S39-46. View abstract
  16. Using Medicaid and CHIP claims data to support pediatric quality measurement: lessons from 3 centers of excellence in measure development. Acad Pediatr. 2014 Sep-Oct; 14(5 Suppl):S76-81. View abstract
  17. Trainee and program director perceptions of quality improvement and patient safety education: preparing for the next accreditation system. Clin Pediatr (Phila). 2014 Nov; 53(13):1248-54. View abstract
  18. Change in adoption of electronic health records by US children's hospitals. Pediatrics. 2013 May; 131(5):e1563-75. View abstract
  19. Pediatric readmission prevalence and variability across hospitals. JAMA. 2013 Jan 23; 309(4):372-80. View abstract
  20. Cost effectiveness of child pneumococcal conjugate vaccination in middle-income countries. Int Health. 2011 Dec; 3(4):270-81. View abstract
  21. Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countries. Int Health. 2011 Dec; 3(4):259-69. View abstract
  22. Electronic health record adoption by children's hospitals in the United States. Arch Pediatr Adolesc Med. 2010 Dec; 164(12):1145-51. View abstract
  23. Higher prevalence of pharyngeal than nasal Staphylococcus aureus carriage in pediatric intensive care units. J Clin Microbiol. 2010 Aug; 48(8):2957-9. View abstract
  24. Influenza vaccination in adolescents with high-risk conditions. Pediatrics. 2008 Nov; 122(5):920-8. View abstract
  25. Pharyngeal carriage of Staphylococcus aureus in pediatric intensive care units. Poster presentation at the Children's Hospital Boston Infectious Diseases Division Research Retreat,. 2008. View abstract
  26. Service-oriented architecture for pediatric immunization decision support. Poster presentation at the American Medical Informatics Association Annual Meeting,. 2007. View abstract
  27. Service-oriented architecture for pediatric immunization decision support. AMIA Annu Symp Proc. 2007 Oct 11; 1056. View abstract
  28. Influenza vaccination in adolescents with high-risk conditions. Poster presentation at the Infectious Diseases Society of America Annual Meeting,. 2007. View abstract
  29. Influenza vaccination in adolescents with high-risk conditions. Podium presentation at the Annual NRSA Research Trainees Conference,. 2007. View abstract
  30. Growth phase- and nutrient limitation-associated transcript abundance regulation in Bordetella pertussis. Infect Immun. 2006 Oct; 74(10):5537-48. View abstract
  31. Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia. Genome Res. 2003 Jun; 13(6B):1273-89. View abstract
  32. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J. 2002 Oct; 21(10):917-22. View abstract